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Abstract
Objective 
To describe a surgical technique and to report using a retrospective study the efficacy of
peritoneal shunts for the treatment of recurrent/chronic subdural hematoma (CSDH). We
describe the considerations, complications, and outcomes related to this technique.
Methods 
In a retrospective cohort study, 125 charts with a diagnosis of subacute/chronic subdural
hematoma were assigned for evaluation. Of the charts reviewed, 18 charts were found from
subjects with a diagnosis of recurrent sub-acute or chronic subdural hematoma. All patients
had undergone initial surgical treatment of their condition followed by peritoneal shunt
placement to help alleviate intracranial pressure. Factors including the age, size of subdural
hematoma, number of previous events, BMI, complications, survival, and clinical course were
analyzed.
Results 
After subdural peritoneal shunt placement all patients had full neurological recovery with no
complaints of headaches, lethargy, weakness, confusion or seizures. None of the cases had new
subdural hematoma episodes after placement for a minimum of a two-year period (mean 26.1
months) (range 24.3-48.6 months). No postoperative complications were reported. The rates of
postoperative hemorrhage, infection, distal catheter revision, and perioperative seizures was
found to be zero percent. Shunt drainage was successful in all cases, draining 85% of the blood
in the first 48 hours. There was no significant relationship between complications and the use
of anticoagulants four weeks after surgery.
Conclusions
Peritoneal shunts, though rarely used, are a viable option in the treatment of sub-acute/chronic
subdural hematomas. When pursuing this treatment, this technique is recommended to
mitigate the risks of repeat surgical intervention and lessen perioperative time in high-risk
patients.
1 2 3 4 5 1
6 7 1
 Open Access OriginalArticle  DOI: 10.7759/cureus.613
How to cite this article
Alvarez-pinzon A M, Stein A A, Valerio J E, et al. (May 18, 2016) Is Subdural Peritoneal Shunt Placement
an Effective Tool for the Management of Recurrent/Chronic Subdural Hematoma?. Cureus 8(5): e613. DOI
10.7759/cureus.613
Categories: Neurosurgery
Keywords: subdural hematoma, shunt, craniotomy, mental status, trauma
Introduction
Recurrent/chronic subdural hematoma is one of the most frequent forms of intracranial
hemorrhages treated by neurosurgeons, and one that may result in compression of brain
parenchyma, mass effect, and subsequent neurological deficits and dysfunction. The
prevalence of CSDH increases with age and is found most commonly afflicting the elderly
population. Despite the frequency of this condition, research indicates that there is a lack of
recommendations for standardized treatment [1]. While surgical management of the condition
may be effective in some cases, complications associated with surgical techniques developed to
manage the condition can result in significant risks to the patient’s health [1,4]. In the aging
population, the existence of various comorbidities can affect the clinical outcome due to
postoperative complications, including the increased risk for hemorrhage in patients receiving
anticoagulant and antiplatelet therapy [2]. Because of the lack of guidance on the treatment of
this condition, various authors have recommended a wide range of treatment options
including: partial resection of the hematoma membrane, large craniectomy, extended
craniotomy or excision of inner and outer parts of the hematoma membrane [4-5]. Overall, the
options carry with them a host of risks for the patient and may not have a significant impact on
improving patient outcomes and/or quality of life [5].
Although various recommendations for the treatment of chronic or recurrent subdural
hematoma have been made, a review of the literature regarding treatment for this condition
does indicate that craniotomy followed by drainage of the hematoma and replacement of the
skull fragment is the most commonly utilized procedure for treating patients
[4]. Decompressive craniectomy is also widely used to reduce intercranial pressure; however, in
this procedure the skull fragment that is removed is not replaced [5]. Even though these
interventions are among the most frequently employed, mortality rates for these procedures
remain high at 60 to 80 percent [5]. Because of the high rate of mortality associated with
craniectomy and craniotomy, recommendations for the use of preoperative trepanation and
drainage are now being more extensively considered in practice [4]. Although, burr hole
craniostomy is the most widely utilized technique, there is an approximate 10-20% recurrence
rate requiring re-operation associated with this method [3]. The approach requires the
placement of a burr hole in the skull to drain the hematoma and reduce pressure [6]. Because
the efficacy of this approach has not been widely supported in the literature, it is primarily used
to alleviate the pressure caused by a subdural hematoma in patients with comorbid conditions
that preclude invasive surgery [6]. With the increasing incidence of chronic SDH in the aging
population, there exists a need for new and refined treatment options that would provide both
minimally invasive approaches while remaining clinically and fiscally efficient.
Trepanation and peritoneal shunting
The use of trepanation (burr hole craniostomy) for the treatment of subdural hematoma does
appear to provide some advantage in improving outcomes for patients with CSDH, especially
those in which repeated invasive surgery is contraindicated. In one study, burr hole trepanation
was compared with craniotomy in a group of 151 patients with subdural hematoma [7]. The
results indicate that the success rate for the burr hole group was 64.3% compared with 52.3% for
the craniotomy group [7]. Based on the data the authors conclude that trepanation may provide
a more viable approach for addressing the needs of patients with subdural hematoma
[7]. Further research on the topic suggests that trepanation followed by the placement of a
peritoneal shunt may also provide additional support for improving patient outcomes
[8]. Individual case reports regarding the use of peritoneal shunts for the treatment of subdural
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hematoma have been reported in the literature [1, 8]. Although peritoneal shunting is still in its
infancy it may represent an important step forward in treating subdural hematoma.
Peritoneal shunting has been the treatment of choice for cerebrospinal fluid (CSF) diversion for
decades [9]. Peritoneal shunts are commonly used in intercranial or spinal spaces to drain
excess fluid in various sites and are often quite successfully utilized [8]. The peritoneal shunt is
a relatively simple device that comprises three parts including the proximal tubing, the valve,
and the distal tubing [8]. Although peritoneal shunts provide an effective tool for reducing the
number of surgical procedures needed by the patient to reduce CSF pressure, these devices do
require consistent monitoring and often fail within one year of placement [9]. Despite the fact
that the literature regarding the use of peritoneal shunts for the treatment of subdural
hematoma is scant, drainage of the hematoma typically occurs on a daily or weekly basis [8]. As
a result, the placement of the peritoneal shunt has the potential to markedly reduce the number
of surgical procedures needed to reduce intercranial pressure and may further be useful for
patients with chronic or recurrent subdural hematoma.
Purpose of the current research
As noted in the current literature the surgical treatment options for subdural hematoma carry
with them considerable risk for the patient [1-2, 4-5, 6, 8]. Burr hole trepanation and peritoneal
shunt placement may provide viable alternatives for reducing mortality associated with
subdural hematoma while providing a cost-effective means for managing patients with
recurrent hematomas [7-8]. While it is reasonable to argue that randomized clinical trials for
evaluating the effectiveness of peritoneal shunt placement for subdural hematomas may raise
some pertinent ethical concerns, it is possible to review patient charts to assess and evaluate
treatments provided. As noted in the literature, techniques such as trepanation and peritoneal
shunt placement are commonly used in patients who are unable to undergo invasive surgical
procedures [1, 7-8]. For this reason, accumulated chart data regarding the use of peritoneal
shunts for the treatment of subdural hematoma should provide important insight into the
viability of this approach for mainstream treatment of this condition. Thus, the purpose of the
current research is to provide a retrospective chart review that evaluates the use of peritoneal
shunt placement in patients with CSDH and the subsequent outcomes in these patients.
Informed consent was obtained from the patients for this study.
Materials And Methods
The method selected for this investigation involved a retrospective cohort review of 125 charts.
The charts assigned for review included those of patients diagnosed with sub-acute/chronic
subdural hematoma. Of the charts reviewed 18 patients were found to have a history of
recurrent sub-acute or chronic subdural hematoma. All patients had undergone initial surgical
treatment of their condition followed by peritoneal shunt placement to help alleviate
intracranial pressure. Factors including age, the size of the hematoma, number of previous
events, body mass index (BMI), complications, survival rates, and clinical course were all
evaluated in an effort to comprehensively assess patient outcomes from the use of peritoneal
shunts. The use of a retrospective cohort analysis provides important insight into peritoneal
shunt treatment without creating additional ethical challenges for examining the use of this
technique, including those associated with an experimental investigation of the approach.
Table 1 describes the patient demographics.
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Patient Demographics
Males 12
Females 6
Total patients 18
Patients with Parkinson's disease 3
Patients with Alzheimer's disease 3
Patients with CVD 10
Mean weight 72.1±9.3
Mean height 173±9.5
BMI 27.4±3.2
Previous trauma 20% 20%
Previous surgery for SDH 100%
ASA category II 6 patients III 11 patients IV 1 patient
TABLE 1: Patient Demographics
Results
The results of the chart analysis provide significant support for the use of peritoneal shunts for
the treatment of subdural hematoma. In particular, the results indicate that all patients
involved in the study experienced full neurological recovery following shunt placement.
Additionally, the data demonstrates that patients with a peritoneal shunt in place did not
experience a new subdural hematoma for a minimum of two years with the average period
being 26.1 months and a range between 24.3 months and 48.6 months. Table 2 further details
all evaluated secondary endpoints. The results further indicate that none of the patients
experienced post-surgical complications and that shunt drainage was successful in all cases
with 85 percent of the blood removed from the hematoma within 48 hours. Table
3 demonstrates complication rates. Four weeks following surgery there were no adverse
complications associated with the use of anticoagulant medications. Figure 1 depicts
preoperative and postoperative CT scans. Compared to Figure 1A (preoperative CT scan
demonstrating large subacute subdural collection), Figure 1B demonstrates stable positioning
of the drainage catheter with resolution of the hematoma and no signs of acute hemorrhage. 
2016 Alvarez-Pinzon et al. Cureus 8(5): e613. DOI 10.7759/cureus.613 4 of 8
Summary of All Evaluated Secondary Endpoints
Mean duration of surgery (minutes) 35.6 ± 12.5
Mean time until full mobility (days) 1.5 ± 1
Neurological recovery time 3.2 days ± 1.5 days
Correct intraperitoneal catheter position 100%
Incidence of recurring SDH at 2 years 30%
TABLE 2: Summary of All Evaluated Secondary Endpoints
Complication Rates
Hemorrhage 0%
Infection 0%
Perioperative seizure 0%
Distal catheter revision 0%
Proximal catheter revision 0%
TABLE 3: Complication Rates
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FIGURE 1: Brain CT Scan Images
Figure 1A: Pre-op brain CT scan image demonstrating a large right subacute subdural
hematoma causing subfalcine herniation, impending uncal herniation, right to the left shift of
1.0 cm mass effect and ipsilateral ventricles.
Figure 1B: Brain CT scan demonstrating status post neurosurgical evacuation of right subdural
hematoma. - Burr holes are present at the parietal convexity. Subdural drainage catheter, stable
in position. Previously present right subdural air has resolved. No extra-axial fluid collections
identified from the level of the foramen of Monro to the convexity. No acute intracranial
hemorrhage.
Discussion
Based on the data obtained from this retrospective chart review, peritoneal shunting is
illuminated as a viable treatment of choice for patients with recurrent or chronic subdural
hematoma. Current research indicates that the recurrence rate of subdural hematoma following
surgery is between 9.2 and 26.5 percent [7]. Common surgical techniques used for the
treatment of this condition have a mortality rate between 60 and 80 percent [6]. Given that the
results of the current study indicate that none of the patients undergoing peritoneal shunt
placement experienced morbidity or mortality as a result of the procedure, peritoneal shunt
placement clearly has a marked advantage over existing surgical techniques. This surgical
technique showed a comparatively safe and efficacious treatment strategy that is less invasive
and cost-effective, for the management and treatment of chronic/sub-acute SDH and
prevention of neurological decline secondary to recurrence of subdural hematoma.
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Limitations
Despite the fact that peritoneal shunt placement appears to be a superior choice for the
treatment of chronic or recurrent subdural hematoma, it is important to note that the current
research has some important limitations. In particular, the current research only identified 18
patients that had this procedure performed. This small sample size is not representative of the
total population of patients who require treatment for subdural hematoma each year. As such,
generalizing the findings for use in all patients with recurrent or chronic subdural hematoma is
not advisable. Further, outcomes for the patients undergoing peritoneal shunt placement were
not compared with outcomes for other patients undergoing procedures such as craniectomy
and craniotomy. Information comparing outcomes may demonstrate that these surgical
procedures provide some notable advantage over peritoneal shunt placement. With these issues
in mind, it becomes evident that some type of comparison is required in order to fully
understand the advantages of peritoneal shunt placement.
Further research
Further research on the topic is clearly needed to elucidate the nuances of this treatment
approach and to determine if it can and should be used in patients who are otherwise healthy
enough to undergo craniectomy and craniotomy. In short, research is needed to compare
peritoneal shunt placement with surgical techniques to determine if shunt placement is a
viable option for patients who can undergo surgical treatment. Broadening the scope of
retrospective chart reviews and comparing surgical groups with shunt placement groups may
provide the most comprehensive data needed to determine if a randomized controlled trial can
be ethically undertaken. By utilizing existing evidence to evaluate outcomes, it should be
possible to draw more definitive conclusions from the research.
Conclusions
Current surgical options for the treatment of subdural hematoma carry with them considerable
complications, which can lead to increased mortality and morbidity. Peritoneal shunt
placement appears to have some advantages for patients experiencing chronic or recurrent
subdural hematomas. The current research provides promising support for the further
investigation of peritoneal shunt placement for the treatment of subdural hematoma. While it
is evident that additional research is needed to explore this technique, there is evidence to
guide inquiry and the further development of methodologies that will help definitively
demonstrate the efficacy of this technique.
Appendices
 
 
Additional Information
Disclosures
Human subjects: Consent was obtained by all participants in this study. Animal subjects:
This study did not involve animal subjects or tissue.
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